Estradiol patch and exercise to reduce side effects of hormone therapy for prostate cancer
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This trial tests if wearing an estradiol patch and doing regular exercise can help lessen the side effects of standard hormone therapy (leuprorelin) given with radiation for prostate cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have localized prostate cancer and are scheduled for radiation therapy.
- You will also receive hormone therapy (leuprorelin injections) for at least 12 months.
- You are over 18 years old and in generally good health (able to do normal activities).
- Your body mass index (BMI) is between 18.5 and 30.
- You do not have any serious heart, blood clot, or liver problems, and you are not allergic to estradiol or leuprorelin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a structured exercise program can help you manage side effects from hormone therapy and radiation for prostate cancer. It aims to improve your overall well-being.
This study tests whether adding resistance exercise (like weight training) during hormone therapy and radiation can improve your immune system and quality of life. It focuses on men starting hormone therapy for localized prostate cancer.
This trial tests a digital exercise program to see if it helps men with prostate cancer stay active while on hormone therapy. You may be able to join if you're starting or already on hormone therapy and also getting radiation therapy.
This study tests whether a supervised exercise program can help men with prostate cancer stay stronger and feel better during combined radiation and hormone therapy. You may be able to join if you are about to start these treatments and are otherwise healthy enough to exercise.
This study tests whether a supervised exercise program can help reduce heart disease risk in men with prostate cancer who are on hormone therapy. Participants will exercise at home or in a group and be monitored for heart health changes.
This study tests whether a combination of short-term hormone therapy (relugolix) and focused radiation (SBRT) can treat a certain type of prostate cancer that is considered favorable but has a higher genetic risk. It aims to find a less intense treatment that still works well.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.